MWVC
MRNA icon

Morgens Waterfall Vintiadis & Co’s Moderna MRNA Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,000
Closed -$5.39M – 33
2021
Q3 		$5.39M Sell
14,000
-9,100
-39% -$3.36M 2.78% 19
2021
Q2 		$5.43M Hold
23,100
– – 2.77% 17
2021
Q1 		$3.02M Buy
+23,100
New +$3.35M 1.68% 26

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's MRNA Position: Q4 2021 in Review

Morgens Waterfall Vintiadis & Co sold out of Moderna (MRNA) in Q4 2021, closing a stake of 14,000 shares — an estimated $5.39M sold.

Morgens Waterfall Vintiadis & Co first reported a position in MRNA in Q1 2021 and held it in 3 quarters. The position peaked at $5.43M in Q2 2021. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Morgens Waterfall Vintiadis & Co reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 14,000 Moderna shares in Q4 2021, an estimated $5.39M.
  • Morgens Waterfall Vintiadis & Co first reported a position in Moderna in Q1 2021 and held it in 3 quarters.
  • Morgens Waterfall Vintiadis & Co's Moderna position peaked at $5.43M in Q2 2021.
  • 1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2021, filed 14 Feb 2022.